Cordant Inc’s Idexx Laboratories IDXX Stock Holding History

Cordant Inc’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$5K	–	620
2022 Q1	$5K	Buy	+9	New	+$4.73K	﹤0.01%	279
2020 Q1	–	Sell	-14	Closed	-$4K	–	114
2019 Q4	$4K	Buy	+14	New	+$3.69K	﹤0.01%	133

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Cordant Inc's IDXX Position: Q2 2022 in Review

Cordant Inc sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 9 shares — an estimated $5K sold.

Cordant Inc first reported a position in IDXX in Q4 2019 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Cordant Inc reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 9 Idexx Laboratories shares in Q2 2022, an estimated $5K.
Cordant Inc first reported a position in Idexx Laboratories in Q4 2019 and held it in 2 quarters.
Cordant Inc's Idexx Laboratories position peaked at $5K in Q1 2022.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.